Macrophi

Macrophi is a preclinical-stage biotechnology company focused on developing innovative macrophage-based drug delivery systems (MDDS). By utilizing the innate ability of macrophages to migrate toward inflammatory and tumor microenvironments, the company engineers these cells to carry and release therapeutic agents directly at the site of disease. This targeted approach is designed to enhance the efficacy of existing treatments while minimizing systemic side effects. Macrophi's primary research areas include oncology, specifically targeting solid tumors, and chronic inflammatory conditions like rheumatoid arthritis. The company's platform aims to overcome biological barriers that often limit the penetration of conventional drugs into dense tumor tissues.